Intramammary antibiotic preparations and their withholding times

The Veterinary Record
|January 11, 1986
PubMed

Insights

The Milk Marketing Board enhanced its antibiotic residue testing sensitivity to 0.01 iu/ml, aligning with Veterinary Products Committee standards for milk safety. This ensures milk quality by limiting penicillin residue concentrations.

Area of Science:

  • Food safety analysis
  • Veterinary medicine
  • Dairy science

Background:

  • The Milk Marketing Board (MMB) previously tested milk for antibiotic residues at 0.02 iu/ml.
  • Regulatory bodies like the Veterinary Products Committee (VPC) review antibiotic preparations for safety.
  • Established guidelines from the Joint FAO/WHO Expert Committee on Food Additives (1969) set acceptable residue limits.

Purpose of the Study:

  • To report the increased sensitivity of the MMB's antibiotic residue testing.
  • To align MMB testing levels with international food additive standards.
  • To ensure the safety and quality of milk by controlling antibiotic residues.

Main Methods:

  • The MMB increased the sensitivity of its penicillin residue test from 0.02 iu/ml to 0.01 iu/ml.
  • The Veterinary Products Committee (VPC) reviewed intra-mammary antibiotic preparations with existing licences.
  • Residue concentration assessments were based on the 1969 FAO/WHO Expert Committee report.

Main Results:

  • The MMB's new testing sensitivity of 0.01 iu/ml for penicillin or equivalent was implemented on January 1, 1986.
  • The VPC's review confirmed that milk residue concentrations should not exceed established FAO/WHO limits.
  • The 0.006 ppm penicillin level, equivalent to 0.01 iu/ml, is the standard adopted by both the VPC and MMB.

Conclusions:

  • The MMB's enhanced testing protocol ensures stricter control over antibiotic residues in milk.
  • Alignment with international standards provides a consistent and reliable measure for milk safety.
  • The updated testing threshold supports the production of high-quality milk free from excessive antibiotic contamination.

Related Concept Videos

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to individual...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...